Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
1.38M
-
Shares change
-
-50.9K
-
Total reported value, excl. options
-
$11.1M
-
Value change
-
-$424K
-
Number of buys
-
5
-
Number of sells
-
-13
-
Price
-
$8.07
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q3 2014
26 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q3 2014.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.38M shares
of 41M outstanding shares and own 3.36% of the company stock.
Largest 10 shareholders include MARXE AUSTIN W & GREENHOUSE DAVID M (790K shares), STIFEL FINANCIAL CORP (388K shares), GREYLIN INVESTMENT MANGEMENT INC (89.5K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (25K shares), D. E. Shaw & Co., Inc. (17K shares), Commerzbank Aktiengesellschaft /FI (15.5K shares), HSBC HOLDINGS PLC (15K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (10.1K shares), MORGAN STANLEY (9.22K shares), and UBS AG (4.39K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.